Navigation Links
5040 Rotary-Retracting Microtome

Products5040 Rotary-Retracting Microtome
Company myNeuroLab.com
Item 5040 Rotary-Retracting Microtome
Features Inquire
Description The popular 5040 microtome is of rotary retracting, self-lubricating design and has a heavy cast alloy base and cutting arm. Its robust construction makes it accurate and incredibly reliable. The use of fixed beryllium hinges means that all lateral motion is controlled and allows no slop or play that can be experienced in other, lesser designs which can result in 'chatter' and 'thick and thinning'. Its pawl and ratchet wheel and head-advance design ensures absolute calibration for section thickness accuracy and repeatability.
Info myNeuroLab.com
Customer Service: (866) 444-0944
Web site: http://www.myneurolab.com

Related medicine products :

1. HM 650 V Vibration Microtome
2. HM 315 Microtome
3. Bright M3500 Microtome
4. Shandon Finesse 325 Microtome
5. Shandon Finesse E+ Microtome
6. Shandon Finesse ME+ Microtome
7. Freezing Stage for Microtome, 38 mm x 38 mm
8. Freezing Stage for Microtome, 76.2 mm x 79.4 mm
9. Freezing Stage for Microtome, 38 mm x 38 mm, 220V
10. Freezing Stage for Microtome, 76.2mmx79.4mm, 220V
11. Manual Radial Microtome - Economy Series
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:
(Date:7/21/2017)... ... July 21, 2017 , ... ... years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could ... after surgery, though activity levels decline over time. The study, presented today at ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: